Procaterol Trade names Meptin, others AHFS/Drugs.com Micromedex Detailed Consumer Information Routes of administration Oral (tablets, syrup), inhalation (DPI) ATC code
(±)-(1R ,2S )-rel -8-Hydroxy-5-[1-hydroxy-2-(isopropylamino)butyl]-quinolin-2(1H )-one
CAS Number PubChem CID ChemSpider UNII KEGG CompTox Dashboard (EPA ) ECHA InfoCard 100.069.606 Formula C 16 H 22 N 2 O 3 Molar mass 290.363 g·mol−1 3D model (JSmol) Chirality Racemic mixture
CC(C)NC(CC)C(O)c2ccc(O)c1NC(=O)C=Cc12
N Y (what is this?) (verify)
Procaterol is a β2 adrenoreceptor agonist used for the treatment of asthma in many countries, but is not approved in the United States. The drug is readily oxidized in the presence of moisture and air, and requires stabilizers for use by inhalation.[ 1]
It was patented in 1974 and came into medical use in 1980.[ 2] Procaterol is similar to salbutamol (albuterol), but has a somewhat more prolonged action. It can be taken orally or by inhalation to treat asthma.
Synthesis
8-Hydroxycarbostyril 1 is acylated with 2-bromobutyric acid chloride 2 at the fifth position of the quinoline system, which gives the compound 3 . This undergoes action of isopropylamine, forming an aminoketone, the carbonyl group of which is reduced by sodium borohydride, giving procaterol 4 .[ 3] [ 4] [ 5] [ 6]
Procaterol synthesis:[ 3] [ 4] [ 5] [ 6]
Names
It is also known as procaterol hydrochloride (USAN).
Procaterol is available under a number of trade names (Onsukil, Masacin, Procadil and others).[ 7]
References
^ US 4616022 , Ghebre-sellassie I, Nesbitt Jr RU, "Procaterol stabilization", published 1984, issued 1986, assigned to Warner Lambert Co LLC
^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery . John Wiley & Sons. p. 543. ISBN 9783527607495 .
^ a b US 4026897 , Nakagawa K, Yoshizaki S, "5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-hydroxycarbostyril derivatives", issued 31 May 1977, assigned to Otsuka Pharmaceutical Co Ltd
^ a b Yoshizaki S, Osaki M, Nakagawa K, Yamura Y (November 1980). "Synthesis of 8-hydroxycarbostyril" . Chemical and Pharmaceutical Bulletin . 28 (11): 3441– 3443. doi:10.1248/cpb.28.3441 .
^ a b Yoshizaki S, Tanimura K, Tamada S, Yabuuchi Y, Nakagawa K (September 1976). "Sympathomimetic amines having a carbostyril nucleus". Journal of Medicinal Chemistry . 19 (9): 1138– 1142. doi:10.1021/jm00231a011 . PMID 10441 .
^ a b Yoshizaki S, Manabe Y, Tamada S, Nakagawa K, Tei S (August 1977). "Isomers of erythro-5-(1-hydroxy-2-isopropylaminobutyl)-8-hydroxycarbostyril, a new bronchodilator". Journal of Medicinal Chemistry . 20 (8): 1103– 1104. doi:10.1021/jm00218a024 . PMID 894683 .
^ "International Drugs: Procaterol" . Drugs.com . Retrieved 7 March 2016 .
Adrenergic receptor modulators
α1
Agonists Antagonists
Abanoquil
ADRIANA
Ajmalicine
Alfuzosin
Anisodamine
Anisodine
Atiprosin
Atypical antipsychotics (e.g., brexpiprazole, clozapine , olanzapine , quetiapine , risperidone )
Benoxathian
Beta blockers (e.g., adimolol, amosulalol, arotinolol, carvedilol , eugenodilol, labetalol )
Buflomedil
Bunazosin
Butanserin
Corynanthine
Dapiprazole
Domesticine
Doxazosin
Ergolines (e.g., acetergamine, ergotamine , dihydroergotamine , lisuride , nicergoline , terguride )
Etoperidone
Fenspiride
Hydroxyzine
Indoramin
Ketanserin
L-765,314
mCPP
Mepiprazole
Metazosin
Monatepil
Moxisylyte
MT-1207
Naftopidil
Nantenine
Neldazosin
Niaprazine
Niguldipine
Pardoprunox
Pelanserin
Perlapine
Phendioxan
Phenoxybenzamine
Phentolamine
Phenylpiperazine antidepressants (e.g., hydroxynefazodone, nefazodone , trazodone , triazoledione)
Piperoxan
Prazosin
Quinazosin
Quinidine
Silodosin
Spegatrine
Spiperone
Talipexole
Tamsulosin
Terazosin
Tiodazosin
Tolazoline
Tetracyclic antidepressants (e.g., amoxapine , maprotiline , mianserin )
Tricyclic antidepressants (e.g., amitriptyline , clomipramine , doxepin , imipramine , trimipramine )
Trimazosin
Typical antipsychotics (e.g., chlorpromazine , fluphenazine , loxapine , thioridazine )
Urapidil
WB-4101
Zolertine
α2
Agonists Antagonists
1-PP
Adimolol
Amesergide
Aptazapine
Atipamezole
Atypical antipsychotics (e.g., asenapine, brexpiprazole, clozapine , lurasidone, olanzapine , paliperidone , quetiapine , risperidone , zotepine)
Azapirones (e.g., buspirone , gepirone, ipsapirone, tandospirone)
BRL-44408
Buflomedil
Cirazoline
Efaroxan
Esmirtazapine
Fenmetozole
Fipamezole
Fluparoxan
Idazoxan
Ketanserin
Lisuride
mCPP
Mianserin
Mirtazapine
NAN-190
Pardoprunox
Phentolamine
Phenoxybenzamine
Piperoxan
Piribedil
Rauwolscine
Rotigotine
Setiptiline
Spegatrine
Spiroxatrine
Sunepitron
Terguride
Tolazoline
Typical antipsychotics (e.g., chlorpromazine , fluphenazine , loxapine , thioridazine )
Yohimbine
β
See also: Receptor/signaling modulators
Dopaminergics
Serotonergics
Monoamine reuptake inhibitors
Monoamine releasing agents
Monoamine metabolism modulators
Monoamine neurotoxins
Drugs for obstructive airway diseases: asthma/COPD (R03)
Adrenergics, inhalants
Short-acting β2 agonists Long-acting β2 agonists Ultra-long-acting β2 agonists
Abediterol
Carmoterol
Indacaterol
Olodaterol
Vilanterol
Other
Glucocorticoids Anticholinergics/ muscarinic antagonist Mast cell stabilizers Xanthines Eicosanoid inhibition
Leukotriene antagonists Arachidonate 5-lipoxygenase inhibitors Thromboxane receptor antagonists Non-xanthine PDE4 inhibitors
Others/unknown Combination products
Aclidinium bromide/formoterol
Beclometasone/formoterol
Beclometasone/formoterol/glycopyrronium bromide
Budesonide/formoterol
Budesonide/glycopyrronium bromide/formoterol
Fluticasone furoate/umeclidinium bromide/vilanterol
Fluticasone furoate/vilanterol
Fluticasone propionate/salmeterol
Glycopyrronium bromide/formoterol
Indacaterol/glycopyrronium bromide
Indacaterol/glycopyrronium bromide/mometasone
Indacaterol/mometasone
Ipratropium bromide/salbutamol
Mometasone/formoterol
Salbutamol (albuterol)/budesonide
Theophylline/ephedrine
Theophylline/ephedrine/hydroxyzine
Theophylline/ephedrine/phenobarbital
Umeclidinium bromide/vilanterol
# WHO-EM
‡ Withdrawn from market
Clinical trials:
† Phase III
§ Never to phase III